Education
About Us
Working with TipRanks
Follow Us
Clinigence Holdings (NUTX)
NASDAQ:NUTX
NUTX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.16 - $152.51
Previous CloseN/A
Volume3.28K
Average Volume (3M)104.72K
Market Cap
$776.80M
Enterprise Value$528.08M
Total Cash (Recent Filing)$43.58B
Total Debt (Recent Filing)$314.28B
Price to Earnings (P/E)15.2
Beta2.26
Next Earnings
May 19, 2025EPS Estimate
-0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)9.27
Shares Outstanding5,528,448
10 Day Avg. Volume169,078
30 Day Avg. Volume104,725
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.08
Price to Cash Flow (P/CF)11.70
P/FCF Ratio3.70
Enterprise Value/Market Cap0.68
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.69
Enterprise Value/Ebitda3.55
Forecast
1Y Price Target
$125.00Price Target Upside-11.04% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Clinigence Holdings News
PremiumCompany Announcements
Clinigence Holdings’ Earnings Call Highlights Robust Growth
PremiumCompany Announcements
Nutex Health Inc. Reports Strong 2024 Financial Turnaround
---
Bulls Say, Bears Say
Bulls Say
Expansion StrategyThe company opened four new facilities in 2024, expanding its network to 24 micro-hospitals, demonstrating its growth and expansion strategy.
Financial PerformanceNutex reported revenue of $257.6M, significantly higher than the previous year's $69.7M, driven by successful rate arbitration with payers.
Financial PositionNutex holds more cash than long-term debt, which reflects a strong financial position.
Bears Say
Market PositionShares currently trade at an EV/revenue multiple of 0.4x our 2025 estimate, below the peer average of 1.6x, excluding NUTX.
Stock ValuationShares currently trade at a discount to peers, reflecting the early stage and unproven nature of Nutex's business model.
---
Ownership Overview
35.02% Insiders
3.63% Mutual Funds
1.25% Other Institutional Investors
56.45% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
NUTX FAQ
What was Clinigence Holdings’s price range in the past 12 months?
Clinigence Holdings lowest stock price was $4.16 and its highest was $152.51 in the past 12 months.
What is Clinigence Holdings’s market cap?
Clinigence Holdings’s market cap is $776.80M.
When is Clinigence Holdings’s upcoming earnings report date?
Clinigence Holdings’s upcoming earnings report date is May 19, 2025 which is in 23 days.
How were Clinigence Holdings’s earnings last quarter?
Clinigence Holdings released its earnings results on Mar 31, 2025. The company reported $11.12 earnings per share for the quarter, beating the consensus estimate of $3.043 by $8.077.
Is Clinigence Holdings overvalued?
According to Wall Street analysts Clinigence Holdings’s price is currently Overvalued.
Does Clinigence Holdings pay dividends?
Clinigence Holdings does not currently pay dividends.
What is Clinigence Holdings’s EPS estimate?
Clinigence Holdings’s EPS estimate is -0.15.
How many shares outstanding does Clinigence Holdings have?
Clinigence Holdings has 5,528,448 shares outstanding.
What happened to Clinigence Holdings’s price movement after its last earnings report?
Clinigence Holdings reported an EPS of $11.12 in its last earnings report, beating expectations of $3.043. Following the earnings report the stock price went up 51.818%.
Which hedge fund is a major shareholder of Clinigence Holdings?
Currently, no hedge funds are holding shares in NUTX
---
Clinigence Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$125.00 (-11.04% Downside)
$125.00 (-11.04% Downside)
Blogger Sentiment
Bearish
NUTX Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 222.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $81.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.8%
Last 30 Days ▼ 11.5%
Last 30 Days ▼ 11.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
1997.47%
12-Months-Change
Fundamentals
Return on Equity
50.22%
Trailing 12-Months
Asset Growth
68.21%
Trailing 12-Months
Company Description
Clinigence Holdings
Nutex Health, Inc. operates as a technology-enabled healthcare services company. It operates through two divisions: Hospital division and Population Health Management division. The Hospital division implements and operates health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 21 facilities in 8 states. The Population Health Management division owns and operates provider networks, such as independent physician associations. Its management services organizations provide management, administrative, and other support services to its affiliated hospitals and physician groups. This division's cloud-based proprietary technology platform aggregates data across multiple information systems, settings, and sources to create a holistic view of each patient and provider, as well as allows to deliver care. The company is based in Houston, Texas.
---
NUTX Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlighted strong financial growth, successful arbitration outcomes, and effective debt management, despite challenges posed by the No Surprises Act and the operational burden of the arbitration process.Read More>---
NUTX Stock 12 Month Forecast
Average Price Target
$125.00
▼(-11.04% Downside)
Technical Analysis
aTyr Pharma
―
Inventiva
―
Compass Therapeutics
―
Olema Pharmaceuticals
―
Candel Therapeutics
―
Best Analysts Covering NUTX
1 Year
1 Year Success Rate
5/10 ratings generated profit
1 Year Average Return
+157.29%
reiterated a buy rating 18 days ago
Copying Bill Sutherland's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +157.29% per trade.
---